位置:首页 > 蛋白库 > SGPL_DROME
SGPL_DROME
ID   SGPL_DROME              Reviewed;         545 AA.
AC   Q9V7Y2; Q0E946;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Sphingosine-1-phosphate lyase {ECO:0000305};
DE            Short=S1PL;
DE            Short=SP-lyase;
DE            Short=SPL;
DE            EC=4.1.2.27 {ECO:0000269|PubMed:12702658};
DE   AltName: Full=Sphingosine-1-phosphate aldolase;
GN   Name=Sply {ECO:0000312|FlyBase:FBgn0010591}; Synonyms=Spl; ORFNames=CG8946;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Van Veldhoven P.P.;
RT   "Functional expression of sphingosine-phosphate lyase from Arabidopsis and
RT   Drosophila.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12702658; DOI=10.1242/dev.00456;
RA   Herr D.R., Fyrst H., Phan V., Heinecke K., Georges R., Harris G.L.,
RA   Saba J.D.;
RT   "Sply regulation of sphingolipid signaling molecules is essential for
RT   Drosophila development.";
RL   Development 130:2443-2453(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   FUNCTION, PATHWAY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-119;
RP   ARG-210 AND SER-335.
RX   PubMed=28165339; DOI=10.1172/jci89626;
RA   Lovric S., Goncalves S., Gee H.Y., Oskouian B., Srinivas H., Choi W.I.,
RA   Shril S., Ashraf S., Tan W., Rao J., Airik M., Schapiro D., Braun D.A.,
RA   Sadowski C.E., Widmeier E., Jobst-Schwan T., Schmidt J.M., Girik V.,
RA   Capitani G., Suh J.H., Lachaussee N., Arrondel C., Patat J., Gribouval O.,
RA   Furlano M., Boyer O., Schmitt A., Vuiblet V., Hashmi S., Wilcken R.,
RA   Bernier F.P., Innes A.M., Parboosingh J.S., Lamont R.E., Midgley J.P.,
RA   Wright N., Majewski J., Zenker M., Schaefer F., Kuss N., Greil J.,
RA   Giese T., Schwarz K., Catheline V., Schanze D., Franke I., Sznajer Y.,
RA   Truant A.S., Adams B., Desir J., Biemann R., Pei Y., Ars E., Lloberas N.,
RA   Madrid A., Dharnidharka V.R., Connolly A.M., Willing M.C., Cooper M.A.,
RA   Lifton R.P., Simons M., Riezman H., Antignac C., Saba J.D., Hildebrandt F.;
RT   "Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis
RT   and adrenal insufficiency.";
RL   J. Clin. Invest. 127:912-928(2017).
CC   -!- FUNCTION: Cleaves phosphorylated sphingoid bases (PSBs), such as
CC       sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine.
CC       Sphingolipid catabolism is required for normal development including
CC       viability, reproduction and muscle development.
CC       {ECO:0000269|PubMed:12702658, ECO:0000269|PubMed:28165339}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sphinganine 1-phosphate = hexadecanal + phosphoethanolamine;
CC         Xref=Rhea:RHEA:18593, ChEBI:CHEBI:17600, ChEBI:CHEBI:57939,
CC         ChEBI:CHEBI:58190; EC=4.1.2.27;
CC         Evidence={ECO:0000269|PubMed:12702658};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000269|PubMed:12702658, ECO:0000269|PubMed:28165339}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:O95470}; Single-pass type III membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Localized to the developing gut primordium during
CC       embryogenesis. {ECO:0000269|PubMed:12702658}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Expression is high in early and late embryos, and then again early in
CC       metamorphosis, followed by reduction to basal levels after eclosion of
CC       adult flies in both males and females. {ECO:0000269|PubMed:12702658}.
CC   -!- DISRUPTION PHENOTYPE: Flies lacking Sply display decreased viability
CC       associated with altered nephrocytes morphology. Altered lipid
CC       metabolism with accumulation of sphingosine-1-phosphate upstream
CC       intermediates is observed. {ECO:0000269|PubMed:28165339}.
CC   -!- SIMILARITY: Belongs to the group II decarboxylase family. Sphingosine-
CC       1-phosphate lyase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ297394; CAC10531.1; -; mRNA.
DR   EMBL; AE013599; AAF57903.1; -; Genomic_DNA.
DR   EMBL; AY052075; AAK93499.1; -; mRNA.
DR   RefSeq; NP_652032.1; NM_143775.3.
DR   RefSeq; NP_725652.1; NM_166215.2.
DR   AlphaFoldDB; Q9V7Y2; -.
DR   SMR; Q9V7Y2; -.
DR   BioGRID; 70079; 3.
DR   IntAct; Q9V7Y2; 2.
DR   MINT; Q9V7Y2; -.
DR   STRING; 7227.FBpp0086158; -.
DR   PaxDb; Q9V7Y2; -.
DR   PRIDE; Q9V7Y2; -.
DR   DNASU; 46059; -.
DR   EnsemblMetazoa; FBtr0087007; FBpp0086158; FBgn0010591.
DR   EnsemblMetazoa; FBtr0087008; FBpp0086159; FBgn0010591.
DR   GeneID; 46059; -.
DR   KEGG; dme:Dmel_CG8946; -.
DR   CTD; 46059; -.
DR   FlyBase; FBgn0010591; Sply.
DR   VEuPathDB; VectorBase:FBgn0010591; -.
DR   eggNOG; KOG1383; Eukaryota.
DR   GeneTree; ENSGT00390000000046; -.
DR   HOGENOM; CLU_028929_1_0_1; -.
DR   InParanoid; Q9V7Y2; -.
DR   OMA; FKDHQFT; -.
DR   OrthoDB; 517323at2759; -.
DR   PhylomeDB; Q9V7Y2; -.
DR   Reactome; R-DME-1660661; Sphingolipid de novo biosynthesis.
DR   SignaLink; Q9V7Y2; -.
DR   UniPathway; UPA00222; -.
DR   BioGRID-ORCS; 46059; 0 hits in 1 CRISPR screen.
DR   ChiTaRS; Sply; fly.
DR   GenomeRNAi; 46059; -.
DR   PRO; PR:Q9V7Y2; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0010591; Expressed in embryonic/larval hemocyte (Drosophila) and 40 other tissues.
DR   Genevisible; Q9V7Y2; DM.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; ISM:FlyBase.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008117; F:sphinganine-1-phosphate aldolase activity; IDA:FlyBase.
DR   GO; GO:0007527; P:adult somatic muscle development; IMP:FlyBase.
DR   GO; GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro.
DR   GO; GO:0030149; P:sphingolipid catabolic process; IMP:UniProtKB.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR002129; PyrdxlP-dep_de-COase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   Pfam; PF00282; Pyridoxal_deC; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   Developmental protein; Endoplasmic reticulum; Lipid metabolism; Lyase;
KW   Membrane; Pyridoxal phosphate; Reference proteome; Signal-anchor;
KW   Sphingolipid metabolism; Transmembrane; Transmembrane helix.
FT   CHAIN           1..545
FT                   /note="Sphingosine-1-phosphate lyase"
FT                   /id="PRO_0000147016"
FT   TOPO_DOM        1..26
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        27..47
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        48..545
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         342
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         119
FT                   /note="E->G: No effect on function in sphingolipid
FT                   catabolic process."
FT                   /evidence="ECO:0000269|PubMed:28165339"
FT   MUTAGEN         210
FT                   /note="R->Q: Decreased function in sphingolipid catabolic
FT                   process."
FT                   /evidence="ECO:0000269|PubMed:28165339"
FT   MUTAGEN         335
FT                   /note="S->I: Loss of function in sphingolipid catabolic
FT                   process."
FT                   /evidence="ECO:0000269|PubMed:28165339"
SQ   SEQUENCE   545 AA;  60305 MW;  26000F4AE43F85FD CRC64;
     MRPFSGSDCL KPVTEGINRA FGAKEPWQVA TITATTVLGG VWLWTVICQD ENLYIRGKRQ
     FFKFAKKIPA VRRQVETELA KAKNDFETEI KKSNAHLTYS ETLPEKGLSK EEILRLVDEH
     LKTGHYNWRD GRVSGAVYGY KPDLVELVTE VYGKASYTNP LHADLFPGVC KMEAEVVRMA
     CNLFHGNSAS CGTMTTGGTE SIVMAMKAYR DFAREYKGIT RPNIVVPKTV HAAFDKGGQY
     FNIHVRSVDV DPETYEVDIK KFKRAINRNT ILLVGSAPNF PYGTIDDIEA IAALGVKYDI
     PVHVDACLGS FVVALVRNAG YKLRPFDFEV KGVTSISADT HKYGFAPKGS SVILYSDKKY
     KDHQFTVTTD WPGGVYGSPT VNGSRAGGII AACWATMMSF GYDGYLEATK RIVDTARYIE
     RGVRDIDGIF IFGKPATSVI ALGSNVFDIF RLSDSLCKLG WNLNALQFPS GIHLCVTDMH
     TQPGVADKFI ADVRSCTAEI MKDPGQPVVG KMALYGMAQS IPDRSVIGEV TRLFLHSMYY
     TPSQK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024